rxstat › Shortages › Brimonidine

Brimonidine (Onreltea) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Aug 18, 2026

Brimonidine has no current shortage reported in Canada. No active reports are on file.

Eye drops used to lower pressure inside the eye.

Products affected
0 / 1
Reports on file
1

Reports by product

Resolved
ONRELTEA
0.33% · GEL · GALDERMA CANADA INC.
DIN 02421208 · ended Jun 20, 2026 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Brimonidine.

Brimonidine is classified under “OTHER DERMATOLOGICAL PREPARATIONS” (ATC D11AX).

Recent changes

Common questions

What is Brimonidine used for?

Eye drops used to lower pressure inside the eye.

When will Brimonidine be back in stock in Canada?

Brimonidine has no active shortage; supply is normal per Health Canada reports.

Why is Brimonidine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (other dermatological preparations)

Hydroquinone Shortage anticipated 0 of 1 reported products affected Crisaborole (Eucrisa) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.